Life Sciences Partners
PE / VC
1991
$3 500 M
Stockholm, Stockholm County, Sweden
Profile
EQT Life Sciences, formerly known as Life Sciences Partners (LSP), is a major life sciences investor based in Europe. With a 30-year history, the firm is notable for its deep bench of over 30 investment professionals, including medical, scientific, and industry experts. This diversity in expertise allows EQT Life Sciences to provide not just capital, but extensive strategic and operational support to its portfolio companies, focusing on transformative impact on patient outcomes.
The firm primarily invests in innovative companies specializing in therapeutics, medical devices, diagnostics, and healthtech. It operates across various stages, from drug development to later-stage MedTech and digital health solutions, with a typical investment range of 10-60 million EUR. Over its 30-year history, EQT Life Sciences has raised approximately 3.5 billion EUR across 12 private funds.
Notable investments include companies focusing on cutting-edge scientific discoveries and unmet clinical needs. These portfolio companies include innovators in drug development, medical technology for neurodegenerative diseases, and digital health solutions designed to enhance the quality of care and reduce costs. EQT Life Sciences is recognized for partnering closely with scientists and entrepreneurs to create impactful healthcare solutions worldwide.
Industry
Life Sciences Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Life Sciences Partners VII
|
Private Equity (PE)
Venture Capital (VC)
|
HealthTech
Energy
Life Sciences
MedTech
Software
Robotics
Other
Medical Devices
Healthcare Services
Foodtech
Food and Beverage
Digital
Biotechnology
|
Series A
Seed
Series B
Late Stage (Series C+)
|
North America
Europe
|
$50-100 m
|
$1130 M
|
January 2021
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.